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Prognostic value of heart rate variability in post-infarction patients
Prognostiþki znaþaj varijabilnosti srþane frekvencije kod bolesnika nakon
infarkta miokarda
Aneta Boškoviü, Nataša Belada, Božidarka Kneževiü
Clinic of Cardiology, Clinical Center of Montenegro, Faculty of Medicine, University of
Montenegro, Podgorica, Montenegro
Abstract
Background/Aim. Depressed heart rate variability (HRV)
indicating autonomic disequilibrium and propensity to ven-
tricular ectopy can be useful for risk stratification in patients
following acute myocardial infarction (AIM). The aim of the
study was to assess heart rate variability as a predictor of all-
cause mortality in post-infarction patients. Methods. We
analyzed the 24-hour electrocardiographic (ECG) record-
ings of 100 patients (80 males) during hospitalization for
AIM. The mean age of patients was 56.99 + 11.03 years.
Time domain heart rate variability analysis was obtained
from 8 to 13 days after index infarction by mean of a 24-
hour ECG recording, and the calculated parameters were:
standard deviation of all normal to normal RR intervals
(SDNN), RRmax-RRmin (difference between the longest
RR interval and the shortest RR interval), mean RR interval.
We also analyzed ventricular premature complexes from the
ECG data. The patients underwent clinical evaluation, labo-
ratory tests and echocardiography. Results. Within a one-
year follow-up period 11 patients experienced death, 10 of
them because of cardiac reason and one because of stroke.
There were significantly lower values of SDNN (60.55 ±
12.84 ms vs 98.38 ± 28.21 ms), RRmax-RRmin (454.36 ±
111.00 ms vs 600.99 ± 168.72 ms) and mean RR interval
(695.82 ± 65.87 ms vs 840.07 ± 93.97 ms) in deceased pa-
tients than in the survivors, respectively (p < 0.01). The de-
ceased patients w er e o f  h i gh e r m ean  ag e , w i th  l o w er l eft
ventricular ejection fraction (0.46 ± 0.05 vs 0.56 ± 0.06 in
survivors), and more frequent clinical signs of heart failure
and ventricular ectopic activity (>  10VPCs/h; p < 0.01).
Multivariate Cox analysis showed that SDNN was a signifi-
cant, independent predictor of all-cause mortality in post-
infarction patients. The other independent predictors were
clinical signs of heart failure – Killip class II and III and
ventricular ectopic activity. Conclusion. Depressed HRV is
an independent predictor of mortality in post-infarction pa-
tients and may provide useful additional prognostic infor-
mation in non-invasive risk stratification of these patients.
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Apstrakt
Uvod/Cilj. Smanjena varijabilnost srÿane frekvencije kao poka-
zatelj neuravnoteženosti autonomnog nervnog sistema i sklono-
sti ka ventrikularnim ekstrasistolama može biti korisna za strati-
fikaciju rizika kod bolesnika nakon akutnog infarkta miokarda.
Cilj studije bio je da se ispita prognostiÿki znaÿaj varijabilnosti
srÿane frekvencije za ukupni mortalitet kod ovih bolesnika.
Metode. Analizirali smo 24-ÿasovno Holter elektrokardiograf-
sko praýenje 100 bolesnika za vreme hospitalizacije zbog akut-
nog infarkta miokarda. Proseÿna starost bolesnika bila je 56,99
+ 11,03 godine, od kojih je bilo 80 muškaraca. Time domain ana-
liza varijabilnosti srÿane frekvencije odreĀivana je od 8. do 13.
dana od nastanka akutnog infarkta miokarda, uz upotrebu 24-
ÿasovnog Holter posmatranja, a izraÿunavani parametri bili su:
standardna devijacija svih normalnih RR intervala (SDNN),
RRmax-RRmin (razlika izmeĀu najdužeg RR intervala i najkra-
ýeg RR intervala) i proseÿni RR interval. Iz Holter posmatranja,
takoĀe, analizirani su ventrikularni poremeýaji ritma. Kod bole-
snika je obavljeno i kliniÿko praýenje, laboratorijski testovi i
ehokardiografsko ispitivanje. Rezultati. Tokom perioda praýe-
nja od godinu dana, 11 bolesnika je umrlo, od ÿega 10 zbog kar-
dijalnog uzroka, a jedan usled cerebro-vaskularnog inzulta. Regi-
strovane su znaÿajno niže vrednosti SDNN (60,55 ± 12,84 ms
vs 98,38 ± 28,21 ms), RRmax-RRmin (454,36 ± 111,00 ms vs
600,99 ± 168,72 ms) i proseÿnog RR intervala (695,82 ± 65,87
ms vs 840,07 ± 93,97 ms) kod umrlih u odnosu na preživele
(p < 0.01). Preminuli bolesnici bili su stariji, sa nižom ejekcio-
nom frakcijom leve komore (0,46 ± 0,05 vs 0,56 ± 0,06), ÿešýim
kliniÿkim znacima srÿane insuficijencije i ventrikularnim pore-
meýajima ritma (> 10VES/h; p < 0,01).  Multivarijantna  Cox
analiza pokazala je da je SDNN znaÿajan, nezavisan prediktor za
ukupni mortalitet kod bolesnika nakon infarkta miokarda. Drugi
nezavisni prognostiÿki faktori bili su kliniÿki znaci srÿane insufi-
cijencije – Killip klasa II i III i uÿestale ventrikularne ekstrasisto-
le. Zakljuÿak. Smanjena varijabilnost srÿane frekvencije je ne-
zavisan prediktor mortaliteta kod bolesnika nakon infarkta mio-
karda i može pružiti korisne dodatne prognostiÿke informacije u
neinvazivnoj stratifikaciji rizika kod ovih bolesnika.
Kljuÿne reÿi:
infarkt miokarda; srce, frekvencija; aritmija; mortalitet;
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Introduction
The process of risk stratification following acute myo-
cardial infarction (AMI) occurs in three stages: initial pres-
entation, hospital course and assessment at hospital dis-
charge 
1. It requires tests which can assess myocardial func-
tion, residual ischemia and propensity for ventricular ar-
rhythmias. The most important determinant for mortality is
left ventricular function, and left ventricular ejection fraction
(LVEF) below 40% is a strong predictor of death in post-
infarction patients 
2. Susceptibility to serious arrhythmias is
reflected in ventricular ectopic activity, and other indicators
of electrical instability such as depressed heart rate variabil-
ity (HRV) or baroreflex sensitivity and an abnormal signal-
averaged electrocardiogram 
3, 4. All of these can identify pa-
tients at increased risk of death. Depressed HRV in post-MI
patients may reflect a decrease in vagal activity directed to
the heart, which leads to prevalence of sympathetic mecha-
nisms and to cardiac electrical instability.
The association of higher risk of post-infarction mortal-
ity with reduced HRV was first shown by Wolf et al. 
5 in
1977. The variation of heart rate may be evaluated by a
number of methods. The simplest to perform is the time do-
main measure of the standard deviation of all normal RR in-
tervals (SDNN), which is most frequently used. More com-
plicated are various spectral methods for the analysis of the
tachogram – frequency domain methods. According to Task
Force of the European Society of Cardiology and North
American Society of Pacing and Electrophysiology, SDNN
is recommended as a measure of HRV in post-infarction pa-
tients; SDNN is calculated over a 24-hour period from a
continuous electrocardiographic (ECG) recording in patients
before discharge from the hospital 
6. SDNN < 70 ms was
used in several independent studies as a cutoff value defining
normal and depressed HRV and a powerful predictor of
mortality and arrhythmic complications in patients after
AMI 
2, 4. The predictive value of HRV is independent of
other factors established for post-infarction risk stratification,
such as depressed LVEF, increased ventricular ectopic activ-
ity, and the presence of ventricular late potentials. In the era
of modern treatment strategies that have modifying role in
prognosis of post-MI patients, such as treatment with beta
blockers, ACE inhibitors, revascularization and implantable
cardioverter defibrillators (ICD), the prognostic significance
of HRV has been challenged.
The aim of this study was to assess prognostic value of
HRV in post-MI patients during the follow-up of one year.
Methods
The study was observational and prospective and in-
cluded 110 patients with AMI who were admitted in the
Coronary Care Unit of Clinical Center of Montenegro in
Podgorica. Entry criteria were the diagnosis of first AMI
with ST elevation, the age of 80 years or younger, and sinus
rhythm. Exclusion criteria were atrial fibrillation or abnormal
sinus node function, valvular disease or cardiomyopathy, and
any other disease limiting survival. The study was approved
by the Ethics Committee of the institution. Since the data
obtained were non-invasive and did not exceed usual clinical
management of the patients, the local Ethics Committee de-
cided that signed informed consent was not needed. How-
ever, we did obtain oral informed consent.
Medical history, physical examination and laboratory
findings were undertaken for all the patients. LVEF was
measured within the two weeks of the index infarction by
two-dimensional echocardiography. HRV and arrhythmia
analysis (frequent ventricular premature complexes-VPCs
> 10 VPCs/hour, VPC couplets and non-sustained ventricu-
lar tachycardia – NSVT) were measured by Holter-
monitoring (24-hour ECG recording). Recordings were ob-
tained from 8 to 13 days after an index infarction and con-
tained at least 19 hours of analyzable ECG data including the
whole night coverage. Biosensor Holter recorders were used.
Tapes were analyzed for ventricular arrhythmias and HRV at
the Holter laboratory of the Clinical Center of Montenegro
by the published methods (a software package of Microsoft
Corporation, after visual and manual editing of RR intervals
and QRS complexes). The measure of HRV chosen for the
primary analysis was SDNN calculated from 24-hour ECG
recording, which represents measure of the global HRV. We
also calculated simple time domain measures of HRV:
RRmax-RRmin (difference between the longest RR interval
– RRmax and the shortest RR interval – RRmin) and the
mean RR interval (mean of all normal RR intervals). All the
patients took their usual medications on the day of ECG re-
cording.
The patients were followed-up for one year with visits
every 6 months. All clinical events during the follow-up pe-
riod were recorded and for patients who died we asked for
the cause of death. The end-point of the study was all-cause
mortality (death from any cause) and sudden cardiac death
(SCD), which occurring instantaneous to 1 hour after the on-
set of a change in clinical status. In seven patients 24-hour
ECG recording was not technically good for interpretation.
We lost contact with three patients during the follow-up of
one year. At the end of the study we had data of 100 patients
for statistical analysis.
The arithmetic mean and standard deviation (ʉ ± SD)
were calculated for continuous variables. Ȥ
2 and Independent
Sample t-test were used to evaluate associations between the
categorical and continuous variables. Statistical analysis was
performed by using the statistical package SPSS 15.0 for
Windows and data base in Microsoft Excel package. For
identification of prognostic factors-predictors we used multi-
variate Cox analysis. A two-tailed p value of less than 0.05
was accepted as significant.
Results
We observed 110 patients, but at the end of the study
we had data of 100 patients for statistical analysis. The mean
age of patients was 56.99 ± 11.03 years, between them 80
were men and 20 women, mean BMI was 26.72 ± 3.44
kg/m
2. Anterior localization of AMI was diagnosed in 44%
of the patients and inferior localization of AMI in 56% of theVolumen 71, Broj 10 VOJNOSANITETSKI PREGLED Strana 927
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patients. Physical examination found that 68% of the patients
had Killip I class, 28% of them Killip II class and 4% of the
patients had Killip III class during the stay in the Coronary
Care Unit; mean LVEF was 0.54 ± 0.07. Analysis of HRV
showed that mean SDNN was 94.22 ± 29.42 ms; 23% of the
patients had SDNN < 70 ms; mean RR interval was 824.20 ±
101.71 ms and mean RRmax-RRmin was 584.86 ± 169.33
ms. Analysis of ventricular ectopic activity found that 16%
of the patients had > 10 VPCs/hour. During a follow-up pe-
riod of one year 11 patients died, 10 of them because of car-
diac reason and one died of stroke. Among the patients who
had cardiac death, 6 patients had SCD and 4 had worsening
of congestive heart failure as a cause of death. Three patients
died in the first 30 days after AMI, two patients had SCD
and the third patient died because of congestive heart failure.
Demographic and clinical characteristics of the patients are
shown in Table 1. There was no difference in revasculariza-
tion strategy between the patients who survived and the de-
ceased patients, 51% of those treated with thrombolysis and
no one with primary PCI (p > 0.05), but treatment with beta
blockers was more frequently used in patients who survived
(p < 0.05), without any differences in other medical therapy.
Analysis of HRV showed significantly lower values of
SDNN (60.55 ± 12.84 ms vs 98.38 ± 28.21 ms), RRmax-
RRmin (454.36 ± 111.00 ms vs 600.99 ± 168.72 ms) and the
mean RR interval, (695.82 ± 65.87 ms vs 840.07 ± 93.97 ms) in
the patients who died than in the survivors (p < 0.01) (Table 2).
The study findings showed depressed HRV – SDNN
< 70 ms in 23 of the patients, and it was more frequent in the
patients who died (9/11), than in those who survived (14/89;
p < 0.01).
Ventricular ectopic activity, the number of ventricular
premature complexes (VPCs) > 10/hour was more frequent
in the patients who died than in the survivors (p < 0.01) (Ta-
ble 3). There was no significant difference in the number of
couplets and episodes of NSVT during Holter monitoring in
patients who died compared to patients who survived
(p > 0.05).
Table 1
Demographic and clinical characteristics of the study population
Characteristics of patients Survived (n = 89) Dead (n = 11) p
Age (years), ʉ ± SD 58.78 ± 10.82 62.83 ± 7.35 < 0.01
Male/Female (n) 72/17 8/3 > 0.05
BMI (kg/m
2), ʉ ± SD 26.62 ± 3.34 27.24 ± 4.21 > 0.05
Smoker (n) 63 7 > 0.05
Hypertension (n) 44 6 > 0.05
Hyperlipidemia (n) 27 3 > 0.05
Diabetes mellitus (n) 14 2 > 0.05
Heart rate at admission (b.p.m.), ʉ ± SD 82.78 ± 21.26 79.82 ± 28.81 > 0.05
Systolic blood pressure (mmHg), ʉ ± SD 138 ± 22 142 ± 24 > 0.05
Diastolic blood pressure (mmHg), ʉ ± SD 89 ± 14 93 ± 12 > 0.05
Hemoglobin (g/l), ʉ ± SD 141 ± 10 136 ± 12 > 0.05
Glucose (mmol/L), ʉ ± SD 7.42 ± 1.25 7.15 ± 1.43 > 0.05
Creatinine (μmol/L), ʉ ± SD 82.38 ± 29.24 85.14 ± 31.18 > 0.05
Total cholesterol (mmol/L), ʉ ± SD 6.21 ± 1.33 6.06 ± 1.42 > 0.05
LDL- cholesterol (mmol/L), ʉ ± SD 4.22 ± 1.24 3.98 ± 1.45 > 0.05
HDL- cholesterol (mmol/L), ʉ ± SD 1.14 ± 0.21 1.20 ± 0.31 > 0.05
Triglycerides (mmol/L), ʉ ± SD 2.01 ± 1.12 1.93 ± 1.23 > 0.05
Sodium (mmol/L), ʉ ± SD 138.11 ± 2.24 139.39 ± 2.95 > 0.05
Potassium (mmol/L), ʉ ± SD 4.32 ± 0.43 4.16 ± 0.36 > 0.05
Creatin kinase Mb peak (IU/L), ʉ ± SD 100.44 ± 83.40 118.39 ± 72.37 > 0.05
Killip class I / II / III (n) 67 / 20 / 2 1  /8 / 2 < 0.01
Left ventricular ejection fraction (%), ʉ ± SD 0.56 ± 0.06 0.46 ± 0.05 < 0.01
BMI – body mass index; LDL – low density lipoprotein; HDL – high density lipoprotein.
Table 2
Heart rate variability and mortality
Parameter Survived
ʉ ± SD
Dead
ʉ ± SD
p
SDNN (ms) 98.38 ± 28.21 60.55 ± 12.84 < 0.001
Mean RR interval (ms) 840.07 ± 93.97 695.82 ± 65.87 < 0.001
RRmax-RRmin (ms) 600.99 ± 168.72 454.36 ± 111.00 0.006
SDDN – standard deviation of all normal RR intervals.
Table 3
Ventricular ectopic activity (> 10 VPCs/hour) and mortality
> 10 VPCs / h Survived Dead F
2 p
Yes 11 5 7.978 0.009
No 78 6
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Multivariate Cox analysis showed that SDNN was a
significant, independent predictor of all-cause mortality and
cardiac mortality in post-infarction patients (p < 0.01),  but
SDNN was not an independent predictor of SCD (p > 0.05).
Also the independent predictors of all-cause mortality and
cardiac mortality were the clinical signs of heart failure –
Killip class II and III, (p < 0.01) and a ventricular ectopic
activity (number of VPCs >  10/hour; p <  0.05) (Table 4).
The independent predictors of SCD were the mean heart rate
(RR 1.14; CI 1.04–1.26, p = 0.0053) and the ventricular ec-
topic activity (the number of VPCs >  10/hour) at Holter
monitoring (RR 17.84; CI 2.03–156.51, p = 0.0093);  the
higher mean heart rate was associated with the higher risk for
SCD.
Discussion
Prediction of fatal events in patients following AMI is
very difficult, especially non-invasive risk stratification. The
assessment of left ventricular function, use of signal-
averaged electrocardiography and Holter monitoring were
shown to be predictive for future mortality and arrhythmic
events in patients after AMI. There is a clear progressive in-
crease in mortality, especially as the LVEF falls <  40% 
2.
Multivariate analysis showed that VPCs frequency and com-
plexity are also an independent risk factor for total cardiac
mortality and SCD 
7–9.
Our study provides evidence that, beside clinical signs
of heart failure and frequent VPCs, HRV has independent
prognostic value in post-MI patients. We demonstrated that
SDNN value was independently inversely associated with
the risk of all-cause mortality after an acute myocardial in-
farction with ST segment elevation, but not with the risk of
SCD. We showed that increased mean heart rate and frequent
ventricular ectopy on post-infarction Holter recording inde-
pendently predicted increased risk of SCD. The knowledge
of a patient’s autonomic status improves risk stratification
over and beyond that obtained from the established clinical
predictors such as clinical signs of heart failure, LVEF, and
ventricular arrhythmias. It has become clear that autonomic
nervous system is very important in the pathogenesis of ven-
tricular arrhythmia and death.
Kleiger et al. 
10 pointed that HRV had the strongest uni-
variate correlation with mortality in 808 post-infarction pa-
tients. Patients with reduced HRV had higher mortality, in-
dependent of the LVEF. Patients with a SDNN < 50 ms had
a relative risk of all-cause mortality of 2.8. These studies
showed that HRV was an independent predictor of death ad-
ditive to other post-infarction risk variables, such as LVEF
and heart rate. Our study showed that the mean heart rate at
Holter monitoring was an independent predictor of SCD ad-
ditive to frequent ventricular ectopic activity (>  10
VPCs/hour).
The results of GISSI-2 study demonstrated that SDNN
< 70 ms was an independent predictor of cardiac mortality in
patients after myocardial infarction 
11. The findings of
ATRAMI study showed that low baroreflex sensitivity and
low SDNN contributed to high risk of cardiac mortality in
post-MI patients and that an altered cardiac substrate, identi-
fied by depressed LVEF and by the presence of frequent
VPCs, was not the sole significant predictor of post-
infarction cardiac mortality 
4. These findings pointed to the
critical role of an altered autonomic balance that resulted in a
relatively high sympathetic activity and a low vagal activity
as showed by low values of baroreflex sensitivity and
SDNN.
A meta-analysis of 51 trials included 3,489 post-
infarction patients with an overall mortality of 125/577
(21.7%) in patients with SDNN <  70 ms compared to
235/2912 (8.1%) in patients with SDNN > 70 ms. The meta-
analysis demonstrated that, after a myocardial infarction, pa-
tients with SDNN <  70 ms had almost four times more
chance to die in the next 3 years than those with SDNN > 70
ms 
12, 13. The results of a CARISMA study suggest that fatal
or near-fatal arrhythmias can be predicted by many risk
stratification methods, especially by heart rate variability, in
patients with reduced LVEF after AMI 
14.
Our findings showed significantly lower SDNN in pa-
tients who died than in those who survived, mortality was
higher in patients with SDNN < 70 ms, and depressed HRV
was an independent predictor of all-cause mortality and car-
diac mortality in post-MI patients in addition to the clinical
signs of heart failure and frequent VPCs. Treatment with
beta blockers was more frequently used in patients who sur-
vived, without a difference in revascularization strategy and
other medical therapy. This observation might explain higher
SDNN and better prognosis in patients treated with beta
blockers. These drugs possibly can increase HRV. The de-
crease in sympathetic activity was noticed in post-infarction
patients using metoprolol 
15 and in patients with heart failure
using acebutolol 
16. Thus, beta blockers are able to restore
the sympathetic–parasympathetic balance in cardiovascular
disease. The deceased patients in our study were of higher
mean age and with lower left ventricular ejection fraction,
too.
Risk stratification of post-infarction patients is impor-
tant since the preventive therapy with ICD is effective in re-
Table 4
Cox analysis of the predictors of all-cause mortality
Variable B S.E. Wald df pr EXP (B)
RR
95% CI
for EXP(B)
Killip class 2.31 0.83 7.79 1 0.0052 0.25 10.11 1.99–51.27
SDNN -0.12 0.03 13.57 1 0.0002 -0.36 0.89 0.84–0.95
> 10 VPCs/h 1.78 0.72 6.10 1 0.0135 0.21 5.90 1.44–24.16
SDNN – standard deviation of all normal RR interval; VPC – ventricular premature complex.Volumen 71, Broj 10 VOJNOSANITETSKI PREGLED Strana 929
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ducing mortality. The guidelines for primary prevention with
ICD in post-infarction patients basically use LVEF for risk
stratification (at least 40 days after AMI) 
17, 18. However,
many deaths occur in low-risk patients with normal LVEF
who do not fulfill criteria for ICD implantation, and some
patients with an ICD do not appear to gain benefit from the
device 
19–21. There is no ideal particular test for risk stratifi-
cation in patients following AMI. There is a need for combi-
nation of tests 
22–26. The findings of some studies showed
combination of LVEF  40% + reduced HRV + frequent
VPCs on Holter monitoring had positive predictive value of
50% 
9. For example in a DINAMIT study, designed to assess
the impact of ICD implantation on top of optimal medical
therapy (OMT) versus OMT alone on all-cause mortality in
high-risk patients within 40 days after AMI, the inclusion
criteria were the occurrence of AMI 6–40 days prior to en-
rollment, LVEF  35%, SDNN  70 ms and the mean RR
interval  750 ms (the last three criteria were used for strati-
fication of high-risk patients) 
27. A review of the literature
suggested staged combination of tests, with Intracardiac
Electrophysiology Study (EPS) last, which allowed 91.8% of
patients to be stratified as either high or low risk 
24, 28. Fur-
ther investigations will be needed to determine the most use-
ful predictive combination of tests for risk stratification in
post-infarction patients.
The limitations of our study include a small number of
patients and a small number of events in each group and
therefore study could be underpowered to detect long-term
mortality difference.
Conclusion
This study shows that depressed heart rate variability is
an independent predictor of mortality in post-infarction pa-
tients additive to clinical signs of heart failure and ventricu-
lar ectopic activity and may provide useful additional prog-
nostic information in non-invasive risk stratification. These
findings suggest that in post myocardial infarction patients
reduction in vagal activity, which is almost always accompa-
nied by a concomitant increase in sympathetic activity, is as-
sociated with higher risk for death. Heart rate variability is
simple, non invasive and relatively not expensive to obtain.
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